RI
| |
RTW INVESTMENTS, LP13F | |
| RTW INVESTMENTS, LP | |
| Last update 2025-05-15 | 68 Stocks (10 new) |
| Value $6.54 Bil | Turnover 8 % |
RTW INVESTMENTS, LP Top Holdings of 2025-03-31
View Full List
| Ticker | | Company | Shares | Value ($1000) | Shares Change % | Weighting % | Trade Impact % | % of Shares outstanding | 3M Change % | YTD Change % | Market Cap $Mil | Industry |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
MDGL | Madrigal Pharmaceuticals Inc | 1,993,687 | 660,368.9 | 0% | 10.100 | 0% | 8.980 | -6.49% | -3.05% | 6,642.6 | Biotechnology | |
ARGX | argenx SE | 673,497 | 398,619.3 | 0% | 6.100 | 0% | 1.100 | -1.46% | -3.78% | 36,088.3 | Biotechnology | |
PTCT | PTC Therapeutics Inc | 7,483,127 | 381,340.2 | +1.22% | 5.830 | +0.07% | 9.440 | -6.52% | +2.61% | 3,671.2 | Biotechnology | |
NTRA | Natera Inc | 2,593,546 | 366,753.3 | +0.01% | 5.610 | 0% | 1.900 | -8.68% | -10.89% | 19,261.9 | Medical Diagnostics & Research | |
AXSM | Axsome Therapeutics Inc | 2,922,729 | 340,877.9 | -27.86% | 5.210 | -1.44% | 5.940 | -0.42% | +24.06% | 5,168.3 | Biotechnology | |
AKRO | Akero Therapeutics Inc | 7,419,340 | 300,334.9 | +8.16% | 4.590 | +0.35% | 9.310 | +23.23% | +81.56% | 4,026.5 | Biotechnology | |
PTGX | Protagonist Therapeutics Inc | 5,719,415 | 276,590.9 | +4.02% | 4.230 | +0.16% | 9.230 | +19.82% | +39.22% | 3,330.9 | Biotechnology | |
RNA | Avidity Biosciences Inc | 8,746,926 | 258,209.3 | +10.26% | 3.950 | +0.37% | 7.260 | +7.37% | +14.20% | 4,002.5 | Biotechnology | |
PEN | Penumbra Inc | 862,770 | 230,713.3 | +0.04% | 3.530 | 0% | 2.230 | -22.82% | -3.07% | 8,913.9 | Medical Devices & Instruments | |
INSM | Insmed Inc | 3,014,558 | 229,980.6 | 0% | 3.520 | 0% | 1.660 | +50.12% | +49.94% | 19,663.8 | Biotechnology |
RTW INVESTMENTS, LP's Historical Top Holdings Breakdowns
RTW INVESTMENTS, LP's Top Stock Picks
View Full List
| Ticker | | Company | Date | Action | Impact % | Price Range | Price | Price Change from Avrg% | Comment | Current Shares | Share Change |
|---|---|---|---|---|---|---|---|---|---|---|---|
BRKR | Bruker Corp | 2025-03-31 | Sold Out Sold Out | -2.20% | 41.74 ($52.03) 62.95 | $40.45 | -22.26% | Sold Out | 0 | -2,481,119 | |
ISRG | Intuitive Surgical Inc | 2025-03-31 | New Buy New Buy | +1.53% | 476.78 ($553.02) 610.45 | $488.61 | -11.65% | New holding | 202,456 | 202,456 | |
AXSM | Axsome Therapeutics Inc | 2025-03-31 | Reduce Reduce | -1.44% | 80.05 ($113.93) 137.75 | $104.97 | -7.86% | Reduce -27.86% | 2,922,729 | -1,128,636 | |
DYN | Dyne Therapeutics Inc | 2025-03-31 | Reduce Reduce | -1.26% | 10.46 ($14.3) 25.46 | $9.24 | -35.38% | Reduce -67.61% | 1,690,567 | -3,528,074 | |
VRNA | Verona Pharma PLC | 2025-03-31 | Add Add | +1.00% | 44.81 ($59.82) 69.63 | $105.00 | 75.53% | Add 56.44% | 2,848,800 | 1,027,781 | |
ETNB | 89bio Inc | 2025-03-31 | Reduce Reduce | -0.65% | 6.1 ($8.74) 11.66 | $9.98 | 14.19% | Reduce -73.69% | 1,967,527 | -5,510,534 | |
GEHC | GE HealthCare Technologies Inc | 2025-03-31 | New Buy New Buy | +0.64% | 78.38 ($85.94) 93.48 | $76.77 | -10.67% | New holding | 520,000 | 520,000 | |
BBNX | Beta Bionics Inc | 2025-03-31 | New Buy New Buy | +0.62% | 11.71 ($18.64) 23.81 | $14.43 | -22.59% | New holding | 3,299,870 | 3,299,870 | |
QURE | uniQure NV | 2025-03-31 | Add Add | +0.54% | 10.6 ($14.02) 18.08 | $15.21 | 8.49% | Add 372.04% | 4,265,428 | 3,361,803 | |
VSTM | Verastem Inc | 2025-03-31 | New Buy New Buy | +0.39% | 5.04 ($6.11) 7.53 | $5.29 | -13.42% | New holding | 4,245,476 | 4,245,476 |
RTW INVESTMENTS, LP Total Holding History ($B)
RTW INVESTMENTS, LP's Asset Allocation
RTW INVESTMENTS, LP Past Portfolios
| Portfolio Date | Number of Stocks | New Stocks | Total Value ($Mil) | Q/Q Turnover |
|---|---|---|---|---|
Top Ranked Articles
- 1
RTW INVESTMENTS, LP's Hypothetical Growth since 2025-03-31
RTW INVESTMENTS, LP's Yearly Returns
| Year | Portfolio % | % | Excess Gain % |
|---|
RTW INVESTMENTS, LP's Holdings Heat Map
Size field:
RTW INVESTMENTS, LP's Holdings Bubble Chart
RTW INVESTMENTS, LP News
- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers